Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Encabo

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Medicina Clinica|June 16, 1990
[Urine determination of CEA, CA50 and TPA as tumor markers in bladder neoplasms]J Morote, M A López-Pacios, G Encabo, et al.
Bulletin Du Cancer|January 1, 1986
Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer)A Ruibal, G Encabo, J Genollá, et al.
Chest|June 1, 1990
Lymphocyte proliferation and gamma-interferon production after "in vitro" stimulation with PPD. Differences between tuberculous and nontuberculous pleurisy in patients with positive tuberculin skin testE Ribera, T Español, J M Martinez-Vazquez, et al.
The International Journal of Biological Markers|May 1, 1986
Circulating CA 15.3 levels in breast cancer. Our present experienceR Colomer, A Ruibal, M Navarro, et al.
Medicina Clinica|November 12, 1983
[Importance of the determination of pregnancy-specific beta 1-glycoprotein (PS1) in patients with germinal tumors undergoing treatment. Correlation with the beta subunit of chorionic gonadotrophic hormone (HCG-beta)]A Ruibal, G Encabo, E Martínez Miralles, et al.
Anticancer Research|July 1, 1986
CA 15.3: early results of a new breast cancer markerR Colomer, L A Sole, M Navarro, et al.
European Urology|April 15, 2000
Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigenJ Morote, C X Raventós, G Encabo, et al.
Actas Urologicas Espanolas|July 31, 1999
[The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen]J Morote Robles, M López López, G Encabo Duro, et al.
Actas Urologicas Espanolas|February 21, 1998
[Influence of renal and hepatic function in the serum concentration of prostate specific antigen]J Morote Robles, G Encabo, J A Lorente, et al.
Actas Urologicas Espanolas|September 17, 1999
[The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer]J Morote Robles, M López Pacios, G Encabo Duró, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Medicina Clinica|June 16, 1990
[Urine determination of CEA, CA50 and TPA as tumor markers in bladder neoplasms]J Morote, M A López-Pacios, G Encabo, et al.
Bulletin Du Cancer|January 1, 1986
Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer)A Ruibal, G Encabo, J Genollá, et al.
Chest|June 1, 1990
Lymphocyte proliferation and gamma-interferon production after "in vitro" stimulation with PPD. Differences between tuberculous and nontuberculous pleurisy in patients with positive tuberculin skin testE Ribera, T Español, J M Martinez-Vazquez, et al.
The International Journal of Biological Markers|May 1, 1986
Circulating CA 15.3 levels in breast cancer. Our present experienceR Colomer, A Ruibal, M Navarro, et al.
Medicina Clinica|November 12, 1983
[Importance of the determination of pregnancy-specific beta 1-glycoprotein (PS1) in patients with germinal tumors undergoing treatment. Correlation with the beta subunit of chorionic gonadotrophic hormone (HCG-beta)]A Ruibal, G Encabo, E Martínez Miralles, et al.
Anticancer Research|July 1, 1986
CA 15.3: early results of a new breast cancer markerR Colomer, L A Sole, M Navarro, et al.
European Urology|April 15, 2000
Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigenJ Morote, C X Raventós, G Encabo, et al.
Actas Urologicas Espanolas|July 31, 1999
[The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen]J Morote Robles, M López López, G Encabo Duro, et al.
Actas Urologicas Espanolas|February 21, 1998
[Influence of renal and hepatic function in the serum concentration of prostate specific antigen]J Morote Robles, G Encabo, J A Lorente, et al.
Actas Urologicas Espanolas|September 17, 1999
[The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer]J Morote Robles, M López Pacios, G Encabo Duró, et al.
Pageof 7